We next delivered C-176 or H-151, a second covalent STING inhibitor, through daily intraperitoneal injections to tumour-bearing immune competent animals after tail-vein inoculation of CINhigh 4T1, B16F10 or CT26 tumour cells. The gene discussed is STING1; the disease is neoplasm.